Podcast - Holistic management and the patient voice
P3 PROSTATE CANCER FORUM 2026
Perspective, Possibilities, Progress1
This live-recorded podcast looks at holistic care and the patient perspective in prostate cancer. It is split into two parts.
This on-demand hub gives you access to a selection of those sessions. The materials are intended to support day-to-day decision-making, encourage multidisciplinary discussion and sit alongside existing guidelines and local protocols.
The videos and PowerPoint presentations have been developed and funded by Bayer plc.
Podcast - Holistic management and the patient voice:
- Part 1 - Patient journey: The team discuss the patient pathway, including psychosexual and psychological determinants of outcomes in prostate cancer.
- Part 2 - Physical activity in metastatic bone disease: The conversation turns to physical activity for patients with metastatic bone disease and how this can be discussed and supported in routine care.
Dr. John McGrane, Consultant Clinical Oncologist, Royal Cornwall Hospitals NHS Trust.
Dr. Michael McGrane, Consultant Clinical Oncologist, Royal Cornwall Hospitals NHS Trust.
Downloadable Slide Sets:
DOWNLOAD SLIDES →
Personalising Treatment in mHSPC - ARI Clinical Landscape
Presented by Prof. Vincent Khoo (Royal Marsden & St George's NHS Foundation Hospitals) - Summarising ARANOTE, ARASENS, and STOPCAP data as presented, with key points on treatment options, intensification strategies, and shared decision-making.
DOWNLOAD SLIDES →
Delivering Personalised Prostate Cancer Care via Shared Decision-Making - Practical Frameworks for mHSPC
Presented by Dr. Simon Hughes (Guy's & St. Thomas' NHS Foundation Trust) - Covering shared decision-making principles in mHSPC, with key points on treatment intensification, quality-of-life trade-offs, and aligning evidence with patient values.
Please refer to the NUBEQA summary of product characteristics before prescribing.
Abbreviations: ARI, androgen receptor inhibitor; mHSPC, metastatic hormone‑sensitive prostate cancer.
PP-NUB-GB-3079 | June 2026